Synopsis
Synopsis
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1-(2,4-dichloro-beta-((p-(phenylthio)benzyl)oxy)phenethyl)imidazole
2. Fenizolan
3. Fenticonazole
4. Fenticonazole Mononitate
5. Laurimic
6. Lomexin
7. Micofulvin
8. Rec 15-1476
9. Terlomexin
1. 73151-29-8
2. Lomexin
3. Falvin
4. Fenticonazole Mononitrate
5. Fenticonazole (nitrate)
6. Rec 15/1476
7. Fenticonazole Nitrate [usan]
8. Rec 15-1476
9. 8v4jgc8yrf
10. 1-[2-(2,4-dichlorophenyl)-2-[(4-phenylsulfanylphenyl)methoxy]ethyl]imidazole;nitric Acid
11. Chebi:83606
12. Alpha-(2,4-dichlorophenyl)-beta,n-imidazolylethyl-4-phenylthiobenzyl Ether Nitrate
13. (+-)-1-(2,4-dichloro-beta-((p-(phenylthio)benzyl)oxy)phenethyl)imidazole Mononitrate
14. 1-(2-(2,4-dichlorophenyl)-2-((4-(phenylthio)benzyl)oxy)ethyl)-1h-imidazole Nitrate
15. Fenticonazole Nitrate (usan)
16. Fenticonazole Nitrate 100 Microg/ml In Acetonitrile
17. Lomexin Nitrate
18. Einecs 277-302-6
19. Unii-8v4jgc8yrf
20. Gynoxin
21. Fenticonazolnitrat
22. Lomexin (tn)
23. Tx 15338
24. 1-[2-(2,4-dichlorophenyl)-2-[(4-phenylsulfanylphenyl)methoxy]ethyl]imidazole; Nitric Acid
25. Rec-151476b Free Base
26. Schembl362708
27. Chembl2107703
28. Dtxsid30993890
29. Rec-151476
30. Bcpp000232
31. Hms3655j11
32. Bcp26349
33. Hy-b0359
34. Ac-426
35. Mfcd00941391
36. S2031
37. Fenticonazole Mononitrate [mi]
38. Fenticonazole Nitrate [mart.]
39. Akos015855521
40. Fenticonazole Nitrate [who-dd]
41. Bcp9000681
42. Ccg-269839
43. 1-(2-(2,4-dichlorophenyl)-2-((4-(phenylthio)phenyl)methoxy)ethyl)-1h-imidazolium Nitrate
44. 1-(2-(2,4-dichlorophenyl)-2-((4-phenylsulfanylphenyl)methoxy)ethyl)imidazole Nitrate
45. Imidazole, 1-(2,4-dichloro-beta-(p-(phenylthio)benzyloxy)phenethyl)-, Nitrate
46. Rec-15/1476
47. 1h-imidazole, 1-(2-(2,4-dichlorophenyl)-2-((4-(phenylthio)phenyl)methoxy)ethyl)-, (+-)-, Mononitrate
48. As-18687
49. 2,2,3,3,4,5-hexachlorobiphenyl
50. Fenticonazole Nitrate [ep Monograph]
51. F1008
52. Ft-0630820
53. Ft-0654253
54. Sw219219-1
55. D02583
56. A837734
57. Q27157007
58. 1-(2-(2,4-dichlorophenyl)-2-(4-(phenylthio)benzyloxy)ethyl)-1h-imidazole Nitrate
59. 1-[2-(2,4-dichlorophenyl)-2-[[4-(phenylthio)phenyl]methoxy]ethyl]imidazole; Nitric Acid
60. (+/-)-1-(2,4-dichloro-.beta.-((p-(phenylthio)benzyl)oxy)phenethyl)imidazole Mononitrate
61. 1h-imidazole, 1-(2-(2,4-dichlorophenyl)-2-((4-(phenylthio)phenyl)methoxy)ethyl)-, (+/-)-, Mononitrate
62. Nitric Acid--1-[2-(2,4-dichlorophenyl)-2-{[4-(phenylsulfanyl)phenyl]methoxy}ethyl]-1h-imidazole (1/1)
63. Rac-1-[2-(2,4-dichlorophenyl)-2-{[4-(phenylsulfanyl)benzyl]oxy}ethyl]-1h-imidazole Nitrate
| Molecular Weight | 518.4 g/mol |
|---|---|
| Molecular Formula | C24H21Cl2N3O4S |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 8 |
| Exact Mass | 517.0629827 g/mol |
| Monoisotopic Mass | 517.0629827 g/mol |
| Topological Polar Surface Area | 118 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 524 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antifungal Agents
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
36
PharmaCompass offers a list of Fenticonazole Nitrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fenticonazole Nitrate manufacturer or Fenticonazole Nitrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fenticonazole Nitrate manufacturer or Fenticonazole Nitrate supplier.
PharmaCompass also assists you with knowing the Fenticonazole Nitrate API Price utilized in the formulation of products. Fenticonazole Nitrate API Price is not always fixed or binding as the Fenticonazole Nitrate Price is obtained through a variety of data sources. The Fenticonazole Nitrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Terlomexin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Terlomexin, including repackagers and relabelers. The FDA regulates Terlomexin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Terlomexin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Terlomexin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Terlomexin supplier is an individual or a company that provides Terlomexin active pharmaceutical ingredient (API) or Terlomexin finished formulations upon request. The Terlomexin suppliers may include Terlomexin API manufacturers, exporters, distributors and traders.
click here to find a list of Terlomexin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Terlomexin DMF (Drug Master File) is a document detailing the whole manufacturing process of Terlomexin active pharmaceutical ingredient (API) in detail. Different forms of Terlomexin DMFs exist exist since differing nations have different regulations, such as Terlomexin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Terlomexin DMF submitted to regulatory agencies in the US is known as a USDMF. Terlomexin USDMF includes data on Terlomexin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Terlomexin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Terlomexin suppliers with USDMF on PharmaCompass.
A Terlomexin CEP of the European Pharmacopoeia monograph is often referred to as a Terlomexin Certificate of Suitability (COS). The purpose of a Terlomexin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Terlomexin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Terlomexin to their clients by showing that a Terlomexin CEP has been issued for it. The manufacturer submits a Terlomexin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Terlomexin CEP holder for the record. Additionally, the data presented in the Terlomexin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Terlomexin DMF.
A Terlomexin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Terlomexin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Terlomexin suppliers with CEP (COS) on PharmaCompass.
A Terlomexin written confirmation (Terlomexin WC) is an official document issued by a regulatory agency to a Terlomexin manufacturer, verifying that the manufacturing facility of a Terlomexin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Terlomexin APIs or Terlomexin finished pharmaceutical products to another nation, regulatory agencies frequently require a Terlomexin WC (written confirmation) as part of the regulatory process.
click here to find a list of Terlomexin suppliers with Written Confirmation (WC) on PharmaCompass.
Terlomexin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Terlomexin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Terlomexin GMP manufacturer or Terlomexin GMP API supplier for your needs.
A Terlomexin CoA (Certificate of Analysis) is a formal document that attests to Terlomexin's compliance with Terlomexin specifications and serves as a tool for batch-level quality control.
Terlomexin CoA mostly includes findings from lab analyses of a specific batch. For each Terlomexin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Terlomexin may be tested according to a variety of international standards, such as European Pharmacopoeia (Terlomexin EP), Terlomexin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Terlomexin USP).
